James Pratt

490 total citations
15 papers, 227 citations indexed

About

James Pratt is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James Pratt has authored 15 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James Pratt's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers) and Alzheimer's disease research and treatments (3 papers). James Pratt is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers) and Alzheimer's disease research and treatments (3 papers). James Pratt collaborates with scholars based in United States, Netherlands and Germany. James Pratt's co-authors include John S. Spratt, Francis R. Watson, Evan Lester, Roy Parker, Ping Zhao, Jürgen B. Bulitta, Ahmad Awada, Axel‐R. Hanauske, Robert D. Arnold and Richard Daifuku and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

James Pratt

13 papers receiving 222 citations

Peers

James Pratt
A. Grothey United States
Maria Maddalena Laterza Italy
Alexandra M. Moore United States
Moyan Zhang China
Fei Yin China
Xingyue Zheng China
Bushra Al‐Ayadhy Kuwait
Shaoliang Han China
Tetsuro Kawazoe Japan
Liuyun Wu China
A. Grothey United States
James Pratt
Citations per year, relative to James Pratt James Pratt (= 1×) peers A. Grothey

Countries citing papers authored by James Pratt

Since Specialization
Citations

This map shows the geographic impact of James Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pratt more than expected).

Fields of papers citing papers by James Pratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pratt. The network helps show where James Pratt may publish in the future.

Co-authorship network of co-authors of James Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of James Pratt. A scholar is included among the top collaborators of James Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pratt. James Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Alstyne, Meaghan Van, James Pratt, & Roy Parker. (2025). Diverse influences on tau aggregation and implications for disease progression. Genes & Development. 39(9-10). 555–581.
2.
Pratt, James, et al.. (2025). Polyserine–tau interactions modulate tau fibrillization. Journal of Biological Chemistry. 301(9). 110523–110523.
3.
Pratt, James, et al.. (2024). Digital Forensic Tools: Comparison of Autopsy TSK and Forensic Explorer. 1–5. 1 indexed citations
4.
5.
Robert, Marie E., Josef Rüschoff, Bharat Jasani, et al.. (2023). High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma. Modern Pathology. 36(5). 100154–100154. 37 indexed citations
6.
7.
Lester, Evan, et al.. (2023). Cytosolic condensates rich in polyserine define subcellular sites of tau aggregation. Proceedings of the National Academy of Sciences. 120(3). e2217759120–e2217759120. 18 indexed citations
8.
Pratt, James, Evan Lester, & Roy Parker. (2021). Could SARS-CoV-2 cause tauopathy?. The Lancet Neurology. 20(7). 506–506. 15 indexed citations
9.
Mitra, Shreya, et al.. (2021). Abstract PS4-18: Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer. Cancer Research. 81(4_Supplement). PS4–18. 1 indexed citations
10.
Prince, Emily, et al.. (2020). Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types. Journal of Clinical Pathology. 73(10). 656–664. 33 indexed citations
11.
Baden, Jonathan, Chen Zhao, James Pratt, et al.. (2019). Comparison of platforms for determining tumour mutational burden (TMB) in patients with non-small cell lung cancer (NSCLC). Annals of Oncology. 30. v25–v25. 2 indexed citations
12.
Bulitta, Jürgen B., Ping Zhao, Robert D. Arnold, et al.. (2008). Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients. Cancer Chemotherapy and Pharmacology. 63(6). 1049–1063. 40 indexed citations
13.
Bulitta, Jürgen B., Ping Zhao, Robert D. Arnold, et al.. (2008). Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients. Cancer Chemotherapy and Pharmacology. 63(6). 1035–1048. 21 indexed citations
14.
Hanauske, A.-R., L. Goedhals, Hans Gelderblom, et al.. (2005). Pharmacokinetics (PK) of free and total paclitaxel after equal doses of paclitaxel injectable emulsion and paclitaxel injection. Journal of Clinical Oncology. 23(16_suppl). 2045–2045. 4 indexed citations
15.
Spratt, John S., Francis R. Watson, & James Pratt. (1970). Characteristics of variants of colorectal carcinoma that do not metastasize to lymph nodes. Diseases of the Colon & Rectum. 13(3). 243–246. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Grothey Breakdown of academic impact, for papers by Maria Maddalena Laterza Breakdown of academic impact, for papers by Alexandra M. Moore Breakdown of academic impact, for papers by Moyan Zhang Breakdown of academic impact, for papers by Fei Yin Breakdown of academic impact, for papers by Xingyue Zheng Breakdown of academic impact, for papers by Bushra Al‐Ayadhy Breakdown of academic impact, for papers by Shaoliang Han Breakdown of academic impact, for papers by Tetsuro Kawazoe Breakdown of academic impact, for papers by Liuyun Wu
Rankless by CCL
2026